These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 16007640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
    Rintala M, Inki P, Klemi P, Jalkanen M, Grénman S.
    Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
    [Abstract] [Full Text] [Related]

  • 13. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG.
    Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
    [Abstract] [Full Text] [Related]

  • 14. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M.
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [Abstract] [Full Text] [Related]

  • 15. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW, Koivurinne K.
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [Abstract] [Full Text] [Related]

  • 16. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
    Tickman RJ, Cohen C, Varma VA, Fekete PS, DeRose PB.
    Acta Cytol; 1990 Aug; 34(4):491-6. PubMed ID: 2197840
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic value of thrombomodulin immunolocalization in serous effusions.
    Ascoli V, Scalzo CC, Taccogna S, Nardi F.
    Arch Pathol Lab Med; 1995 Dec; 119(12):1136-40. PubMed ID: 7503662
    [Abstract] [Full Text] [Related]

  • 18. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR, Cibas ES, Hornick JL, Qian X.
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [Abstract] [Full Text] [Related]

  • 19. Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients.
    Kayser K, Böhm G, Blum S, Beyer M, Zink S, André S, Gabius HJ.
    J Pathol; 2001 Feb; 193(2):175-80. PubMed ID: 11180163
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations.
    Wieczorek TJ, Krane JF.
    Cancer; 2000 Oct 25; 90(5):312-9. PubMed ID: 11038429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.